Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01764919 · ClinicalTrials.gov registry record · Phase 2
[124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection
A Phase 2 study, sponsored by BioMed Valley Discoveries.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT01764919 is a Phase 2 study that was terminated before completion, run by BioMed Valley Discoveries. The registered enrollment target is 4 participants.
The verdict
NCT01764919, a Phase 2 study, was terminated before completion, sponsored by BioMed Valley Discoveries.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
This protocol will evaluate the sensitivity and specificity of \[124I\]FIAU as a diagnostic imaging agent for the detection of osteomyelitis in patients with diabetic foot infection.
Interventions
- RADIATION [124I]FIAU
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01764919
The ClinicalTrials.gov registry entry for NCT01764919 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioMed Valley Discoveries, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [124I]FIAU is the first listed.
NCT01764919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01764919 about?
NCT01764919 is a clinical study titled "[124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection". This protocol will evaluate the sensitivity and specificity of \[124I\]FIAU as a diagnostic imaging agent for the detection of osteomyelitis in patients with diabetic foot infection.
What is the current status of trial NCT01764919?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2013-04. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01764919?
The interventions under investigation include: [124I]FIAU (RADIATION).
Who is sponsoring clinical trial NCT01764919?
This trial is sponsored by BioMed Valley Discoveries, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.